Adan Medical Innovation to present at the Biotech Showcase™ Annual Conference on January 8-10 2018.
Barcelona/ January 5th – Adan Medical Innovation today announced that Joaquim Trias, chairman of the company, will present at Digital Medicine & Medtech Showcase, as a part of Biotech Showcase 2018, to be held in San Francisco on January 8–10 during JP Morgan 2018, the largest annual healthcare investment symposium.
Date: Tuesday, January 9, 2018
Time: 4:00 PM (PST)
Room: Cyril Magnin III, Level 4th Floor
Venue: Parc 55 San Francisco Hotel, 55 Cyril Magnum St, San Francisco, CA (United States)
Adan Medical Innovation is a company focused on the development of integrated digital solutions to improve the management of anaphylaxis, a severe allergic reaction. Its main product under development, anAPPhylaxis, is a smart case for epinephrine auto-injectors, the only effective treatment, connected to a mobile app. The combination of these two components makes patients’ life easier, allowing them to monitor the good quality of the drug, alerting them when auto-injector is forgotten and executing an automated emergency protocol when used, among other features. A clinical trial performed in one of the largest hospitals in Europe (Tertiary University Hospital Vall d’Hebron) has proved the satisfaction and effectiveness of this medical device. The company is raising 3,5M$ for manufacturing, first marketing actions and pipeline development (eg. Smart box for public spaces).
Xavier Guillem, CEO of Adan Medical said “We are very proud of have been chosen to present after a selection process with large competition. This is a great opportunity to show our company to potential investors and partners”
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that Adan Medical Innovation will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”
Adan Medical Innovation is a privately held biotechnology firm committed to make a difference in the lives of individuals, families and caregivers who manage an epinephrine auto-injector. Created by Dr. Anna Sala and Dr. Adrià Curran after daily interaction with patients and their challenges, the company counts with the collaboration of biotech and pharmaceutical industry experts. The company has received several grants and endorsements from key opinion leaders in the field.
Violeta Heras, Project Specialist
Adan Medical Innovation SL
C/Anglí 31, 4-1
08017 Barcelona (Spain)
T: (+34) 932188882